Wells Fargo Initiates Coverage On Versigent with Overweight Rating, Announces Price Target of $35
Benzinga Newsdesk 7 months ago
NewsPrice TargetInitiationAnalyst Ratings
Wells Fargo analyst Colin Langan initiates coverage on Versigent (NYSE:VGNT) with a Overweight rating and announces Price Target of $35.
Wells Fargo analyst Colin Langan initiates coverage on Versigent (NYSE:VGNT) with a Overweight rating and announces Price Target of $35.